PE39996A1 - Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar - Google Patents
Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumarInfo
- Publication number
- PE39996A1 PE39996A1 PE1995272089A PE27208995A PE39996A1 PE 39996 A1 PE39996 A1 PE 39996A1 PE 1995272089 A PE1995272089 A PE 1995272089A PE 27208995 A PE27208995 A PE 27208995A PE 39996 A1 PE39996 A1 PE 39996A1
- Authority
- PE
- Peru
- Prior art keywords
- nicotine
- ansia
- smoking
- symptoms
- absence
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 2
- 229960002715 nicotine Drugs 0.000 title abstract 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000391 smoking effect Effects 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- NOOLISFMXDJSKH-ZDGBYWQASA-N (2s,5r)-5-methyl-2-propan-2-ylcyclohexan-1-ol Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1O NOOLISFMXDJSKH-ZDGBYWQASA-N 0.000 abstract 1
- TWIGRPWEDIAXGX-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dione;1,3,7-trimethylpurine-2,6-dione Chemical compound O=C1NC(=O)NC2=C1NC=N2.CN1C(=O)N(C)C(=O)C2=C1N=CN2C TWIGRPWEDIAXGX-UHFFFAOYSA-N 0.000 abstract 1
- 241000218645 Cedrus Species 0.000 abstract 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- -1 TREMENTINE Substances 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960005233 cineole Drugs 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229940100652 nasal gel Drugs 0.000 abstract 1
- 235000019488 nut oil Nutrition 0.000 abstract 1
- 239000010466 nut oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26466694A | 1994-06-23 | 1994-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE39996A1 true PE39996A1 (es) | 1996-10-03 |
Family
ID=23007084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995272089A PE39996A1 (es) | 1994-06-23 | 1995-06-22 | Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar |
Country Status (6)
| Country | Link |
|---|---|
| AU (1) | AU2702795A (fr) |
| IL (1) | IL114130A0 (fr) |
| MA (1) | MA23586A1 (fr) |
| PE (1) | PE39996A1 (fr) |
| WO (1) | WO1996000069A1 (fr) |
| ZA (1) | ZA955033B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2340397A (en) * | 1996-03-21 | 1997-10-10 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
| AUPO108596A0 (en) * | 1996-07-18 | 1996-08-08 | Collier, Gregory | Treatment of obesity |
| CA2325106A1 (fr) * | 1999-12-06 | 2001-06-06 | Stanley L. Gore | Compositions et methodes permettant de liberer des agents actifs dans le cerveau |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| WO2004104493A2 (fr) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Procede de regulation thermique uniforme d'un substrat ; unite de chauffage integree et unite d'administration de medicaments recourant a ce procede |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| CA2576961A1 (fr) | 2004-08-12 | 2006-03-02 | Alexza Pharmaceuticals, Inc. | Dispositif de distribution de drogue par aerosol integrant des conditionnements thermiques actionnes par percussion |
| EP2121088B1 (fr) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Unité chauffante à utiliser dans un dispositif d'administration de médicament |
| WO2019152873A1 (fr) | 2018-02-02 | 2019-08-08 | Alexza Pharmaceuticals, Inc. | Dispositif aérosol à condensation électrique |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778677A (en) * | 1981-07-09 | 1988-10-18 | Ebbesen Gerald K | Method for treatment of nicotine craving |
| US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
| DE3506406A1 (de) * | 1985-02-23 | 1986-08-28 | Hans-Josef 5600 Wuppertal Stromberg | Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten |
| US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| US4959380A (en) * | 1988-12-19 | 1990-09-25 | Wilson Jordan E | Method of treating people to stop smoking and composition |
| US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
-
1995
- 1995-06-09 WO PCT/US1995/007380 patent/WO1996000069A1/fr not_active Ceased
- 1995-06-09 AU AU27027/95A patent/AU2702795A/en not_active Abandoned
- 1995-06-13 IL IL11413095A patent/IL114130A0/xx unknown
- 1995-06-16 MA MA23929A patent/MA23586A1/fr unknown
- 1995-06-19 ZA ZA955033A patent/ZA955033B/xx unknown
- 1995-06-22 PE PE1995272089A patent/PE39996A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA955033B (en) | 1996-02-15 |
| MA23586A1 (fr) | 1995-12-31 |
| AU2702795A (en) | 1996-01-19 |
| WO1996000069A1 (fr) | 1996-01-04 |
| IL114130A0 (en) | 1995-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE39996A1 (es) | Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar | |
| BR9812615A (pt) | Composições farmacêutica para tratar vìcio de tabaco ou vìcio de nicotina, para aliviar os sintomas da abstinência de nicotina ou para facilitar a cessação de fumar, para tratar vìcio de cocaìna e efeitos da abstinência associados, para tratar dependência alcoólica e efeitos da abstinência associados, e, processos para tratar vìcio de tabaco ou vìcio de nicotina, para aliviar os sintomas de abstinência de nicotina ou para facilitar a cessação de fumar, para tratar vìcio de cocaìna e efeitos da abstinência associados e, para tratar dependência alcoólica e efeitos da abstinência associados | |
| BRPI0317463B8 (pt) | composto, composição farmacêutica compreendendo o mesmo e uso do referido composto no preparo de um medicamento para tratar uma doença amilóide de transtiretina | |
| ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
| BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
| ES2135460T3 (es) | Composicion para ayudar a dejar de fumar. | |
| BR9811249A (pt) | Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma | |
| ES2004856A4 (es) | Agente tensioactivo pulmonar natural, procedimiento de preparacion y composiciones farmaceuticas. | |
| NL194748B (nl) | Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten. | |
| PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
| ES2160707T3 (es) | Composiciones que comprenden agentes deteriorantes del adn y p53. | |
| BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
| SE8503762L (sv) | Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa | |
| NO990595D0 (no) | Anvendelse av chelateringsmiddelet clikinol ved fremstilling av en farmas°ytisk sammensetning for behandling av alzheimers sykdom | |
| DE68924537D1 (de) | Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak. | |
| BR9914631A (pt) | Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades | |
| PE33396A1 (es) | Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar | |
| PE11399A1 (es) | Combinacion de loratadina y un descongestionante para el tratamiento del asma | |
| BR0010515A (pt) | Sistema terapêutico de ministração transdérmica, processo para mascarar um odor desagrádavel e uso de um óleo essencial em um sistema terapéutico de ministração transdérmica | |
| BR0311747A (pt) | Composição farmacêutica, forma de dose simples ou de múltiplas doses da composição, kit, e, método para tratar doença | |
| PT90249A (pt) | Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t | |
| IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
| ES2039433T3 (es) | Una formulacion farmaceutica. | |
| NO990450L (no) | Behandling av sinnslidelser | |
| Pi et al. | Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |